Apyx Medical Corporation (APYX)

Market Cap	59.10M
Revenue (ttm)	48.54M
Net Income (ttm)	-28.44M
Shares Out	37.64M
EPS (ttm)	-0.82
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	75,891
Open	1.540
Previous Close	1.560
Day's Range	1.540 - 1.606
52-Week Range	0.967 - 2.800
Beta	1.27
Analysts	Hold
Price Target	n/a
Earnings Date	Nov 8, 2024

About APYX

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company’s Helium Plasma Technology products are marketed and sold under the Renuvion name in the c...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jan 1, 1987
• Employees: 252
• Stock Exchange: NASDAQ
• Ticker Symbol: APYX
• Website: https://apyxmedical.com

Financial Performance

In 2023, Apyx Medical's revenue was $52.35 million, an increase of 17.61% compared to the previous year's $44.51 million. Losses were -$18.71 million, -19.28% less than in 2022.